December 2, 2013
Australian Prescriber
NPS MedicineWise (Australia)
Editorial commentary on off-label use of available prescription medications in Australia.
"There is no legal impediment to prescribing off label, however the onus is on the prescriber to defend their prescription for an indication that is not listed in the product information. If, in the opinion of the prescriber, the off-label prescription can be supported by reasonable quality evidence, for example the indication is identified in the Australian Medicines Handbook, the prescriber should proceed if this is in the patient’s best interests."
Richard Day is:
- Director of Clinical Pharmacology and Toxicology at St Vincent’s Hospital, Sydney
- Professor of Clinical Pharmacology, St Vincent’s Hospital Clinical School and Pharmacology, School of Medical Sciences, Faculty of Medicine, University of New South Wales
https://www.nps.org.au/copyright
What you can do
You can:
- view content on this website for private or academic use
- download, display, print or reproduce content on this website in unaltered, complete form, subject to the following conditions:
- it is only for personal, non-commercial use, or for non-commercial use within your organisation, and
- you must fully acknowledge NPS MedicineWise as copyright owner, eg © NPS MedicineWise. Reproduced with permission. Visit www.nps.org.au
document
pharmaceuticals